about
Missense mutations and evolutionary conservation of amino acids: evidence that many of the amino acids in factor IX function as "spacer" elementsWhy does the human factor IX gene have a G + C content of 40%?The pattern of factor IX germ-line mutation in Asians is similar to that of CaucasiansThe rates of G:C-->T:A and G:C-->C:G transversions at CpG dinucleotides in the human factor IX geneA Polymorphism in the IL-5 Gene is Associated with Inhibitor Development in Severe Hemophilia A PatientsHemophilia home treatment. Economic analysis and implications for health policy.Mutations causing hemophilia B: direct estimate of the underlying rates of spontaneous germ-line transitions, transversions, and deletions in a human gene.The rates and patterns of deletions in the human factor IX gene.US Hemophilia Treatment Center population trends 1990-2010: patient diagnoses, demographics, health services utilization.Molecular pathology of haemophilia A in Turkish patients: identification of 36 independent mutations.Spectrum of factor VIII mutations in Arab patients with severe haemophilia A.Haemophilia B Brandenberg-type promoter mutation.Intron 22 inversions in the Turkish haemophilia A patients: prevalence and haplotype analysis.Analysis of five polymorphic DNA markers for indirect genetic diagnosis of haemophilia A in the Brazilian population.Risk factors associated with inhibitor development in Chinese patients with haemophilia B.Frequency of recent retrotransposition events in the human factor IX gene.A past mutation at isoleucine 397 is now a common cause of moderate/mild haemophilia B.
P2860
Q35196882-6DC6D2B4-2BC3-4C19-9C3B-7711D6F0EB8AQ35196891-0501D719-F4FB-4354-A1BD-407F7011223DQ35198045-5FC359E6-009B-4D3B-A806-FB2C55DCBD16Q35889375-987F849B-A870-4F7F-AE61-57C8AC227758Q38914615-2ED1B372-99C8-44BC-AC9B-54976952C2E4Q40550240-D6B07879-AB8B-4A16-A85E-400308BE3929Q40584423-86E57030-DDE0-4A82-B961-8CBFD2D67832Q42559632-2C64E2FC-DC23-4B29-BE73-0091BEC966E7Q43662496-2B75BE64-FB17-4BE1-BD33-4811EBE4252DQ43735993-66DA3E35-203E-44A7-AE93-95EA07EEFE4EQ44958757-8317CFEA-5A5C-4763-ACC8-39A48D4036ACQ45857763-F60DE873-0FD5-424E-A203-B0A080AD7D5DQ45861257-5CF530A4-7701-4F05-B64A-800BD05B67C0Q45870716-E45AD4AF-7E1F-463C-B4AB-D64FF724D894Q45875494-6FE37282-FF02-4693-A63C-F06FC9D59590Q45877644-C1427816-00B5-4F21-A097-6E29C173B653Q45883473-8D13DE3D-2746-4917-AB9B-23FE0C093797
P2860
description
1980 nî lūn-bûn
@nan
1980年の論文
@ja
1980年学术文章
@wuu
1980年学术文章
@zh
1980年学术文章
@zh-cn
1980年学术文章
@zh-hans
1980年学术文章
@zh-my
1980年学术文章
@zh-sg
1980年學術文章
@yue
1980年學術文章
@zh-hant
name
The Pennsylvania hemophilia program 1973-1978.
@en
The Pennsylvania hemophilia program 1973-1978.
@nl
type
label
The Pennsylvania hemophilia program 1973-1978.
@en
The Pennsylvania hemophilia program 1973-1978.
@nl
prefLabel
The Pennsylvania hemophilia program 1973-1978.
@en
The Pennsylvania hemophilia program 1973-1978.
@nl
P2093
P356
P1476
The Pennsylvania hemophilia program 1973-1978.
@en
P2093
Djerassi I
Shapiro SS
P304
P356
10.1002/AJH.2830090306
P577
1980-01-01T00:00:00Z